Silvant Capital Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.17M Sell
2,735
-2,687
-50% -$1.1M 0.02% 159
2026
Q2
$2.11M Hold
5,422
– – 0.06% 147
2026
Q1
$2.57M Sell
5,422
-51
-0.9% -$25.7K 0.09% 123
2025
Q4
$2.56M Hold
5,473
– – 0.09% 121
2025
Q3
$2.33M Sell
5,473
-309
-5% -$120K 0.08% 119
2025
Q2
$2.22M Hold
5,782
– – 0.08% 124
2025
Q1
$2M Hold
5,782
– – 0.09% 124
2024
Q4
$1.74M Hold
5,782
– – 0.07% 129
2024
Q3
$2.35M Sell
5,782
-740
-11% -$271K 0.1% 114
2024
Q2
$2.1M Hold
6,522
– – 0.09% 115
2024
Q1
$2.18M Hold
6,522
– – 0.1% 114
2023
Q4
$1.77M Sell
6,522
-15
-0.2% -$3.71K 0.09% 117
2023
Q3
$1.61M Hold
6,537
– – 0.1% 124
2023
Q2
$1.98M Sell
6,537
-2
-0% -$556 0.11% 109
2023
Q1
$1.72M Hold
6,539
– – 0.11% 113
2022
Q4
$1.57M Sell
6,539
-15
-0.2% -$3.36K 0.11% 117
2022
Q3
$1.2M Buy
+6,554
New +$1.31M 0.08% 122

Other funds holding HCA

Silvant Capital Management's HCA Position: Q3 2026 in Review

Silvant Capital Management reduced its HCA Healthcare (HCA) stake by 50% in Q3 2026, selling an estimated $1.1M and leaving 2,735 shares worth $1.17M. The position accounts for 0.02% of the portfolio, ranked #159.

Silvant Capital Management first reported a position in HCA in Q3 2022 and has held it in 17 quarters since. The position peaked at $2.57M in Q1 2026. 1,358 funds tracked by Wall St. Rank hold HCA as of Q3 2026.

  • Silvant Capital Management held 2,735 shares of HCA Healthcare worth $1.17M as of Q3 2026.
  • Silvant Capital Management sold 2,687 HCA Healthcare shares in Q3 2026, an estimated $1.1M.
  • HCA Healthcare made up 0.02% of Silvant Capital Management's portfolio in Q3 2026, its #159 holding.
  • Silvant Capital Management first reported a position in HCA Healthcare in Q3 2022 and has held it in 17 quarters since.
  • Silvant Capital Management's HCA Healthcare position peaked at $2.57M in Q1 2026.
  • 1,358 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2026.

Based on Silvant Capital Management's 13F filing for Q3 2026, filed 9 Nov 2026.